Another notable gainer is Zhu Yi, chairman of Biokin Pharmaceutical, whose net worth more than doubled to $8.2 billion. The company’s subsidiary, SystImmune, signed an $8.4 billion deal last year with ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Timmy Shen is an Asia editor for The Block. Previously, he wrote about crypto and Web3 for Forkast.News from Taiwan after spending more than three years in Beijing covering finance, entertainment ...
Shen reported for The Baltimore Evening Sun in the late 1980s and then for 17 years was a staff writer for The Washington Post. An award-winning writer on The Post’s Metro staff, she covered Maryland ...
CLICK HERE FOR THE FULL INTRODUCTION AND METHODOLOGY.